Loading Super Carl
Super Carl logo Super Carl Get Started
McKesson logo

McKesson

Hospitals and Health Care • Irving, United States

Welcome to the official LinkedIn page for McKesson Corporation. We're an impact-driven healthcare organization dedicated to “Advancing Health Outcomes For All.” As a global healthcare company, we touch virtually every aspect of health. Our leaders empower our people to lead with a growth mindset and deliver excellence for our customers, partners, and the wellbeing of people, everywhere. We work with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services that make quality care more accessible and affordable. Delivering better health outcomes for our employees, our communities, and our environment.…

Website ↗ LinkedIn ↗

Headcount

23,903

10,001+ employees

Hiring

818

Open roles

Revenue Signal

$398B

Estimated annual revenue

Last Round

$0

Most recent funding amount

Company details

Industry

Hospitals and Health Care, Medical Equipment Manufacturing, IT Services and IT Consulting, Pharmaceutical Manufacturing

Categories

Non-Profit Organization, Pharmaceutical Distribution, Healthcare IT, Practice Management, Supply Chain Management, Medication Adherence, Pharmacy Management, Medical Supplies

Company Size

10,001+ employees

Headquarters

Irving, United States

People associated with McKesson

Public profile links appear as mapped users become available.

Additional profile 1
Additional profile 2

See all associated people in Super Carl

Unlock full people graph coverage for this company and access every associated profile.

Get started

Recent jobs

  • CMM Technology Intern

    Columbus • Volunteer • Posted May 2026

  • Field Reimbursement Manager

    New York • Full-time • Posted May 2026

  • Additional job 1
  • Additional job 2

Unlock full company intelligence in Super Carl

Get complete hiring signals, full people graph coverage, and AI-assisted outreach workflows.

Get started
Skip to main content
↻